Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan A. Dyckerhoff Sells 7,814 Shares

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) Director Stefan A. Dyckerhoff sold 7,814 shares of the company’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $107.17, for a total value of $837,426.38. Following the transaction, the director now directly owns 121,803 shares of the company’s stock, valued at approximately $13,053,627.51. This represents a 6.03 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Astera Labs Stock Performance

Shares of ALAB stock opened at $99.60 on Thursday. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $113.85. The stock’s 50-day moving average price is $73.12 and its 200 day moving average price is $60.57.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The firm had revenue of $113.10 million during the quarter, compared to the consensus estimate of $97.50 million. Astera Labs’s quarterly revenue was up 47.1% on a year-over-year basis. As a group, equities research analysts anticipate that Astera Labs, Inc. will post -0.45 EPS for the current year.

Analyst Ratings Changes

ALAB has been the subject of a number of research analyst reports. Roth Mkm upped their price target on Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Evercore ISI dropped their target price on shares of Astera Labs from $98.00 to $80.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Craig Hallum boosted their price target on shares of Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Barclays upped their price objective on shares of Astera Labs from $70.00 to $87.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Finally, Stifel Nicolaus lifted their target price on Astera Labs from $80.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $94.67.

Check Out Our Latest Stock Report on Astera Labs

Institutional Trading of Astera Labs

Several hedge funds and other institutional investors have recently made changes to their positions in the company. FMR LLC lifted its position in Astera Labs by 0.7% in the third quarter. FMR LLC now owns 23,504,038 shares of the company’s stock valued at $1,231,377,000 after purchasing an additional 153,491 shares during the period. Fred Alger Management LLC raised its stake in shares of Astera Labs by 1,361.0% during the 3rd quarter. Fred Alger Management LLC now owns 2,821,921 shares of the company’s stock worth $147,840,000 after buying an additional 2,628,765 shares in the last quarter. Vanguard Group Inc. acquired a new stake in shares of Astera Labs in the 1st quarter valued at approximately $127,268,000. Maverick Capital Ltd. boosted its stake in shares of Astera Labs by 16.0% in the third quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company’s stock valued at $60,575,000 after buying an additional 159,480 shares in the last quarter. Finally, Westfield Capital Management Co. LP acquired a new position in Astera Labs during the third quarter worth $52,049,000.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Recommended Stories

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.